Published in Arthritis Rheum on August 23, 1976
The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up. Ann Rheum Dis (1983) 1.61
Treatment of severe rheumatoid arthritis. Br Med J (Clin Res Ed) (1986) 1.10
Number needed to treat (NNT): implication in rheumatology clinical practice. Ann Rheum Dis (2003) 1.09
Regulation of secondary antibody responses in rodents. I. Potentiation of IgG production by cyclophosphamide. Clin Exp Immunol (1979) 0.91
Rheumatoid knee synovitis successfully treated with intra-articular rifamycin SV. Ann Rheum Dis (1982) 0.85
Comparative activity of ifosfamide and cyclophosphamide. Cancer Chemother Pharmacol (1986) 0.84
Course of dermal ulcers and musculoskeletal involvement in systemic sclerosis patients in the scleroderma lung study. Arthritis Care Res (Hoboken) (2010) 0.79
Evaluation of the immunosuppressive effects of cyclophosphamide in patients with multiple sclerosis. Clin Exp Immunol (1982) 0.77
Assessing the progression of joint damage in rheumatoid arthritis. Drugs (1986) 0.75
Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med (1977) 10.09
Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med (1969) 4.76
Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis. J Exp Med (1982) 3.06
Humoral and cellular sensitivity to collagen in type II collagen-induced arthritis in rats. J Clin Invest (1978) 2.84
Gram-negative sepsis: detection of endotoxemia with the limulus test. With studies of associated changes in blood coagulation, serum lipids, and complement. Ann Intern Med (1972) 2.79
Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States. J Rheumatol (1989) 2.67
Nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice. J Clin Invest (1982) 2.29
Collagen-induced arthritis in rats. Evaluation of early immunologic events. Arthritis Rheum (1979) 2.16
Collagen autoimmune arthritis. Annu Rev Immunol (1984) 2.10
Diffuse fasciitis with eosinophilia: a new syndrome? Trans Assoc Am Physicians (1975) 1.71
Collagen-induced arthritis in rats. Comparison of vitreous and cartilage-derived collagens. Arthritis Rheum (1979) 1.71
Studies in familial systemic lupus erythematosus. Medicine (Baltimore) (1976) 1.70
Transforming growth factor beta 1 (TGF-beta 1) induced neutrophil recruitment to synovial tissues: implications for TGF-beta-driven synovial inflammation and hyperplasia. J Exp Med (1991) 1.55
Collagen-induced arthritis in mice. Localization of an arthritogenic determinant to a fragment of the type II collagen molecule. J Exp Med (1985) 1.52
The occurrence of cryoproteins in synovial fluid; the association of a complement-fixing activity in rheumatoid synovial fluid with cold-precipitable protein. J Clin Invest (1971) 1.51
Incidence and specificity of antibodies to types I, II, III, IV, and V collagen in rheumatoid arthritis and other rheumatic diseases as measured by 125I-radioimmunoassay. Arthritis Rheum (1983) 1.51
Collagen-induced arthritis in rats: antigen-specific suppression of arthritis and immunity by intravenously injected native type II collagen. J Immunol (1983) 1.49
Serum transfer of collagen-induced arthritis. II. Identification and localization of autoantibody to type II collagen in donor and recipient rats. Arthritis Rheum (1983) 1.48
Collagen-induced polyarthritis in rats: a study of native type II collagen for adjuvant activity. J Immunol (1980) 1.43
The 'CREST' syndrome. Comparison with systemic sclerosis (scleroderma). Arch Intern Med (1979) 1.42
The joint disease of sarcoidosis. Ann Rheum Dis (1967) 1.38
Diffuse fasciitis with eosinophilia. A clinicopathologic study. Am J Med (1980) 1.31
Diffuse fasciitis with hypergammaglobulinemia and eosinophilia: a new syndrome? J Rheumatol (1984) 1.30
Topics in clinical medicine. Complement levels in disease. Johns Hopkins Med J (1967) 1.29
Acceleration of onset of collagen-induced arthritis by intra-articular injection of tumour necrosis factor or transforming growth factor-beta. Clin Exp Immunol (1992) 1.22
Cell-mediated immunity to collagen and collagen alpha chains in rheumatoid arthritis and other rheumatic diseases. Am J Med (1980) 1.21
Hashimoto's disease. A clinicopathological study with matched controls. Lack of significant associations with other "autoimmune" disorders. Lancet (1965) 1.17
Autoantibodies and nephritis in the white strain (NZW) of New Zealand mice. Arthritis Rheum (1969) 1.17
Preliminary criteria for the classification of systemic lupus erythematosus (SLE). Evaluation in early diagnosed SLE and rheumatoid arthritis. Arthritis Rheum (1974) 1.16
Type II collagen autoimmunity in otosclerosis and Meniere's Disease. Science (1982) 1.16
Delayed hypersensitivity in systemic lupus erythematosus. Ann Rheum Dis (1968) 1.15
Passive transfer studies with type II collagen antibody in B10.D2/old and new line and C57Bl/6 normal and beige (Chediak-Higashi) strains: evidence of important roles for C5 and multiple inflammatory cell types in the development of erosive arthritis. Arthritis Rheum (1987) 1.14
Auricular chondritis in rats. An experimental model of relapsing polychondritis induced with type II collagen. J Exp Med (1981) 1.12
Impaired cell-mediated immunity in systemic lupus erythematosus (SLE). A controlled study of 23 untreated patients. Am J Med (1975) 1.09
Hashimoto's disease. A search for associated disorders in 170 clinically detected cases. Lancet (1966) 1.08
Type II collagen-induced autoimmune sensorineural hearing loss and vestibular dysfunction in rats. Ann Otol Rhinol Laryngol (1983) 1.04
Cranial nerve involvement in systemic sclerosis (scleroderma): a report of 10 cases. Medicine (Baltimore) (1980) 1.02
Performance of a rosette assay between lymphocytes and sheep erythrocytes at elevated temperatures to study patients with cancer and other diseases. Clin Immunol Immunopathol (1976) 0.98
Connective tissue disease and the chronic biologic false-positive test for syphilis (BFP reaction). Med Clin North Am (1966) 0.98
Type II collagen-induced autoimmune otospongiosis. A preliminary report. Ann Otol Rhinol Laryngol (1983) 0.97
Effect of cyclophosphamide, hydrocortisone and levamisole on collagen-induced arthritis in rats. Arthritis Rheum (1981) 0.97
The role of collagen autoimmunity in animal models and human diseases. J Invest Dermatol (1982) 0.95
Assessment of the potential pathogenicity of type II collagen autoantibodies in patients with rheumatoid arthritis. Evidence of restricted IgG3 subclass expression and activation of complement C5 to C5a. Arthritis Rheum (1986) 0.93
Arthritis in viral hepatitis. Report of two cases and review of the literature. Johns Hopkins Med J (1973) 0.92
Colonic perforations in systemic lupus erythematosus. Medicine (Baltimore) (1975) 0.91
Critical role of peripheral blood phagocytes and the involvement of complement in tumour necrosis factor enhancement of passive collagen-arthritis. Clin Exp Immunol (1993) 0.89
Complement in synovial fluid. Johns Hopkins Med J (1970) 0.89
Characterization of macrophage migration inhibitory factor activity produced in vivo by a cell-mediated immune reaction in the guinea pig. J Immunol (1976) 0.88
Complement-fixing activity of rheumatoid synovial fluid. Ann Rheum Dis (1972) 0.88
Significance of nuclear immunofluorescent patterns. Ann Rheum Dis (1969) 0.87
Histocompatibility antigens in systemic lupus erythematosus. Arthritis Rheum (1976) 0.87
Papular mucinosis. A clinicopathologic study of four patients. Arch Dermatol (1982) 0.86
Myelomonocytic leukaemia following cyclophosphamide therapy of rheumatoid disease. Ann Rheum Dis (1975) 0.84
Partial dissociation of rheumatoid synovial fluid cryoprotein: micro-complement fixation by IgG- or IgG and IgM-containing fractions and denatured calf thymus DNA. J Immunol (1971) 0.84
Adjuvant-induced arthritis in rats. Evidence that autoimmunity to homologous collagens types I, II, IX and XI is not involved in the pathogenesis of arthritis. Clin Exp Immunol (1990) 0.84
Type II collagen-induced arthritis. Ann N Y Acad Sci (1985) 0.84
Proceedings: Impaired cell-mediated immunity in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Arthritis Rheum (1974) 0.83
Heightened circulating antibody responses in New Zealand mice. J Lab Clin Med (1971) 0.83
Physicochemical and immunological studies of the renatured alpha 1(II) chains and isolated cyanogen bromide peptides of type II collagen. Coll Relat Res (1985) 0.82
The immune response of guinea-pigs to type II collagen: poor cross-reactivity with homologous type II collagen accounts for resistance to collagen-induced arthritis. Immunology (1988) 0.81
Collagen-induced arthritis in rodents. A review of clinical, histological and immunological features. Ryumachi (1984) 0.81
Identification of Neisseria gonorrhoeae in synovial membrane by electron microscopy. J Infect Dis (1974) 0.81
Research directions in osteoporosis. Am J Med (1988) 0.80
Reciprocal skin grafts in systemic sclerosis (scleroderma). Arthritis Rheum (1971) 0.80
The association of Sjögren's syndrome and primary pulmonary hypertension. Hum Pathol (1993) 0.79
Letter: Cause of adult toxic epidermal necrolysis. N Engl J Med (1975) 0.79
Autoantibodies to type II collagen. Mayo Clin Proc (1984) 0.79
Arthritis and collagenous colitis. Ann Intern Med (1994) 0.79
Lymphocyte surface markers in human disease. Adv Intern Med (1977) 0.78
Proceedings: Serologic abnormalities and their significance in localized scleroderma. Arthritis Rheum (1976) 0.78
The eosinophilia-myalgia syndrome: the Los Alamos Conference. J Rheumatol (1991) 0.77
Immunopathogenic mechanisms in type II collagen autoimmune arthritis. Pathol Immunopathol Res (1986) 0.77
Acute leukemia following cyclophosphamide therapy for Sjögren's syndrome. Johns Hopkins Med J (1978) 0.76
Failure of calcitonin to inhibit collagen-induced arthritis in rats. Agents Actions (1982) 0.76
Fat necrosis from intramuscular aurothioglucose. J Rheumatol (1994) 0.75
Intraarticular progestins in rheumatic diseases. J Rheumatol (1990) 0.75
HTLV-I myelopathy. Neurology (1992) 0.75
Diagnosing Wilson disease. Ann Intern Med (1992) 0.75
Overlapping polymyositis and ulcerative colitis: HTLV-1 infection as an alternative explanation. J Rheumatol (1991) 0.75
Misleading features of benign spinal cord tumors. Report of three cases. JAMA (1966) 0.75
Proceedings: Comparison of early patterns of rheumatoid arthritis (RA) in juveniles and young adults: data supporting a unified disease concept. Arthritis Rheum (1976) 0.75
Clinical significance of antinuclear antibodies with hypocomplementemia. Johns Hopkins Med J (1973) 0.75
Research in pediatric rheumatology. J Rheumatol (1994) 0.75
Alkaline phosphatase activity of synovial leukocytes. Johns Hopkins Med J (1971) 0.75
Continuing education for the clinical investigator. Arthritis Rheum (1968) 0.75
Analysis of dimethyl sulfoxide immunosuppression in the rat model of collagen II autoimmune arthritis: an effect dependent upon intraperitoneal administration and associated with toxicity. Agents Actions (1985) 0.75
A therapeutic approach to osteoarthritis. Md State Med J (1969) 0.75
Hematological abnormalities in scleroderma. A study of 180 cases. Acta Haematol (1980) 0.75
Rheumatic disease clinics of North America. AIDS and rheumatic disease. Introduction. Rheum Dis Clin North Am (1991) 0.75
American Rheumatism Association. Presidential address. Whither or wither. Arthritis Rheum (1976) 0.75
Competing on capabilities: the new rules of corporate strategy. Harv Bus Rev (1992) 0.75